September 14, 1999
Cardioquin Tablets (Quinidine - Polygalcturonate)
Recalled by The P.F. Laboratories, Inc.
Totowa, NJ (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that The P.F. Laboratories, Inc. is recalling
Cardioquin Tablets because of tablet discoloration (darker-due to oxidation product).
Cardioquin Tablets (Quinidine Polygalcturonate), 275
mg, in 100 tablet bottles, Rx used to treat significant cardiac arrhythmias.NDC
Recall #D-412-9. Class II
Lot #77L1 EXP 5/2004.
The P.F. Laboratories, Inc., Totowa, New Jersey (responsible firm)
The Purdue Frederick Company, Norwalk, Connecticut, by telephone on June 16 and 17,
1999, and by fax on June 18, 1999. Firm- initiated recall ongoing.
360 bottles were distributed; firm estimated that 122 bottles remained on market at
time of recall initiation.
Safety Alerts compiles comprehensive safety
recall information for the United States. SafeMail is a free email service to warn
consumers of faulty products and contaminated foods. For complete information regarding
current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.